Chairman and CEO Khurram Sheikh will host the live call on Wednesday, November 4, 2026 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time; investors may register now and submit questions through the ...

IDEXX Laboratories Inc. (NASDAQ:IDXX) shares advanced 2.57% in pre-market trading on Monday after the veterinary diagnostics company reported stronger-than-expected third-quarter 2026 results and ...

STOCKHOLM, SE / ACCESS Newswire / November 3, 2026 / Vicore Pharma Holding AB (STO:VICO)(NASDAQ:VCRE), a biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, ...

DataMEDS AI, Inc. (NASDAQ:MEDS) has announced that its pharmacy subsidiary, Corexa Health, has entered into a commercial supply agreement covering bulk drug substances and active pharmaceutical ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.

Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...

The Recapitalization eliminates approximately $96 million of annual cash interest on the Senior Notes Substantial new capital and liquidity: $400 million of new money through a rights offering of new ...

Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the third quarter ended September 30, ...

USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), today announced that it will release financial results for the quarterly period ended September 30, 2026, after U.S. markets close on Monday, ...

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time. Upon closing, ...

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing, the combined company ...